Cas:55317-02-7 2-methoxy-1-(2,4,6-trihydroxyphenyl)ethanone manufacturer & supplier

Chemical Name:2-methoxy-1-(2,4,6-trihydroxyphenyl)ethanone

CAS.NO:55317-02-7

Synonyms:ethanone,2-methoxy-1-(2,4,6-trihydroxyphenyl);2-methoxy-1-(2,4,6-trihydroxyphenyl) ethanone;2′,4′,6′-trihydroxy-1-methoxyacetophenone;2-methoxy-1-(2,4,6-trihydroxyphenyl)ethan-1-one;2-Methoxy-1-(2,4,6-trihydroxy-phenyl)-aethanon;2′,4′,6′-trihydroxy-2-methoxyacetophenone

Molecular Formula:C₉H₁₀O₅

Molecular Weight:198.17300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:86.99000

Exact Mass:198.05300

LogP:0.63250

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethanone,2-methoxy-1-(2,4,6-trihydroxyphenyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′,4′,6′-trihydroxy-2-methoxyacetophenone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methoxy-1-(2,4,6-trihydroxyphenyl) ethanone Use and application,2-Methoxy-1-(2,4,6-trihydroxy-phenyl)-aethanon technical grade,usp/ep/jp grade.

Related News: “Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization. 1-ethyl-3-o-tolylurea manufacturers With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. 6H-[2]benzopyrano[4,3-b]pyridin-6-one suppliers Although biocatalysis is globally acknowledged to be a valuable means of ensuring greener, more sustainable manufacturing, its implementation has reached stasis after increasing steadily for the past 10 – 15 years. 1-acetoxy-2-[4-(11H-dibenzo[b,e]azepin-6-yl)-piperazin-1-yl]-ethane vendor & factory Although biocatalysis is globally acknowledged to be a valuable means of ensuring greener, more sustainable manufacturing, its implementation has reached stasis after increasing steadily for the past 10 – 15 years. ,“Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization.